US Patent 7902203 Anti-infective agents
Patent 7902203 was granted and assigned to Abbott on March, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+106 characters)
Article
Patent abstract
The present invention provides an HCV polymerase inhibiting compound having the formula (I)
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07902203 Anti-infective agents US Patent 7902203 Anti-infective agents
Infobox
Patent Number
0790220300
Patent Number
790220300
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079022030
Date of Patent
March 8, 2011
0Patent Application Number
106995130
Date Filed
October 31, 2003
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079022030
Date of Patent
March 8, 2011
0Patent Application Number
106995130
Date Filed
October 31, 2003
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07902203 Anti-infective agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07902203
Date of patent
March 8, 2011
Patent application number
10699513
Date Filed
October 31, 2003
Patent primary examiner
Find more entities like US Patent 7902203 Anti-infective agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.